Frank T Zenke

11PUBLICATIONS
94CO-AUTHORS
Molecular targetsProteins and peptidesRadiation therapyBioassays
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 12, 2024
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications.

Yvette Drew, Frank T Zenke, Nicola J Curtin

|Mar 11, 2024
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs.

Ukhyun Jo, Yasuhiro Arakawa, Astrid Zimmermann

|Dec 14, 2023
Mapping combinatorial drug effects to DNA damage response kinase inhibitors.

Hanrui Zhang, Julian Kreis, Sven-Eric Schelhorn

|Nov 08, 2023
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.

Manja Friese-Hamim, Maria J Ortiz Ruiz, Olga Bogatyrova

|Sep 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.

Adrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan

Pageof 2